newsfilter
← Latest News
Business Wire·

PhaseBio Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2021 on July 15

PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P. Mow will